drugset / Trial / NCT00092742

Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)

NCT00092742

Phase 3 Completed 4086 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the long-term safety of an investigational drug versus an approved drug for the relief of pain in patients with rheumatoid arthritis.

Timeline

Start
2003-02
Primary completion
2005-12
Completion
2005-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 75 mg
Subject Etoricoxib Small molecule 90 mg

Indications